Global Dopamine Agonist Drug
Market – Industry Trends and
Forecast to 2028
Global Dopamine Agonist Drug Market, By Type (Non-Ergoline
Dopamine Agonists, Ergot-Derived Dopamine Agonists,
Recombinant Factor VIII and Others), Indication (Parkinson's
Disease, Restless Leg Syndrome and Others), Drugs (Carbidopa
and Levodopa, Ropinirole, Pramipexole, Cabergoline,
Bromocriptine and Others), Route of Administration (Oral,
Injectable), End- Users (Hospitals, Homecare, Specialty Clinics,
and Others), Distribution Channel (Hospital Pharmacies, Retail
Pharmacies)
Browse Full Report :
https://www.databridgemarketresearch.com/reports/glob
al-dopamine-agonist-drug-market
1
databridgemarketresearch.com US : +1-888-387-2818 UK : +44-161-394-0625 sales@databridgemarketresearch.com
Report Description
The dopamine agonist drug market is expected to gain market growth in the
forecast period of 2021 to 2028. Data Bridge Market Research analyses that
the market is growing with the CAGR of 4.8% in the forecast period of 2021
to 2028.Dopamine agonists are a class of drugs that activates postsynaptic
dopamine receptors directly into the brain. It is generally used to treat the
symptoms of Parkinson’s disease (PD). It basically works by reducing the
motor fluctuations in the individual suffering from Parkinson’s disease.
Get Details TOC :
https://www.databridgemarketresearch.com/toc/?dbmr=globaldopamine-agonist-drug-market
2
databridgemarketresearch.com US : +1-888-387-2818 UK : +44-161-394-0625 sales@databridgemarketresearch.com
Major Key Players
Some of the major players operating in this market are :
•
•
•
•
•
•
•
•
GlaxoSmithKline plc
Intas Pharmaceuticals Ltd
Amarin Corporation
Acorda Therapeutics
Kirin Holdings Company
Bausch Health Companies Inc
Boehringer Ingelheim International GmbH
Intecpharma, Merck & Co
Inquire Before Buying :
https://www.databridgemarketresearch.com/inquire-beforebuying/?dbmr=global-dopamine-agonist-drug-market
3
databridgemarketresearch.com US : +1-888-387-2818 UK : +44-161-394-0625 sales@databridgemarketresearch.com
Market Segmentation
Type
• Non-ergoline dopamine
agonists
• Ergot-derived dopamine
agonists
• Recombinant factor VIII
• Others
Drugs
• Carbidopa and levodopa
• Ropinirole
• Pramipexole
• Cabergoline
• Bromocriptine
• Others
Get Exclusive Sample Report:
https://www.databridgemarketresearch.com/request-asample/?dbmr=global-dopamine-agonist-drug-market
databridgemarketresearch.com US : +1-888-387-2818 UK : +44-161-394-0625 sales@databridgemarketresearch.com
Regional Analysis
Based on geography, the market is segmented into five geographical
regions

North America

Europe

Asia-Pacific

South America

Middle East

Africa
5
databridgemarketresearch.com US : +1-888-387-2818 UK : +44-161-394-0625 sales@databridgemarketresearch.com
About Data Bridge Market
Research
An absolute way to forecast what future holds is to comprehend the trend
today!
Data Bridge Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in the
market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Read Continue : http://databridgemarketresearch.com/about-us/
Contact Us :
Sopan Gedam
Sopan.gedam@databridgemarketresearch.com
6
databridgemarketresearch.com US : +1-888-387-2818 UK : +44-161-394-0625 sales@databridgemarketresearch.com